Health and Wellness
The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.
The launch of the WayFinding platform comes just weeks after the company announced it secured $126 million in funding.
Whole Health Rx will be powered by WellSync, which develops customizable telehealth services for businesses.
The organizations will codevelop an atrial fibrillation program that provides clinical decision support tools and patient coaching between clinical visits.
The venture will leverage new technologies and therapies for remote patient monitoring to ease provider burnout and allow patients to receive more personalized care.
The company's new offerings will allow users to determine their cardiovascular age and overall cardiovascular health.
The companies will utilize Flatiron Clinical Pipe to connect electronic health records to electronic data capture for clinical trial data gathering.
Payments and revenue cycle-management company Sift Healthcare, nursing-scheduling and management platform In-House Health, and analytics and risk-stratification company OptMyCare also secured funding.
It will validate BrainEye's 60-second eye movement test to about 500 participants.
The company notified the SEC of a data breach after discovering an unauthorized party stole consumers' sensitive information, including patient health data.